ACB - Latest News

Aurora Cannabis Inc. (ACB), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NASDAQ.

Market capitalization stands near $164.8M. Beta to the broader market is 1.35.

The article list below shows the most recent ACB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ACB Headlines

ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?

zacks.com - Jul 15, 2026

Aurora Cannabis' shares plunge 28% in three months as a cautious fiscal 2027 outlook overshadows record medical cannabis growth and global expansion.

Aurora Named to TIME Canada's Best Companies 2026 List

prnewswire.com - Jul 9, 2026

NASDAQ | TSX: ACB The Company makes history as the first and only cannabis company to ever receive this recognition EDMONTON, AB, July 9, 2026 /PRNews

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

prnewswire.com - Jul 8, 2026

Shareholders are encouraged to keep an eye out for their meeting materials and vote  early – every vote matters, no matter how many shares you own. S

Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs

zacks.com - Jun 12, 2026

ACB frames fiscal 2027 as a reset year as Canadian reimbursement pressure weighs on margins, even as global medical cannabis growth continues.

Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - Buy

seekingalpha.com - Jun 12, 2026

Aurora Cannabis reported Q4/FY2026 results largely in line with expectations previously outlined by management. In recent months, the company has mad

How News Affects ACB Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ACB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ACB news questions

What is the latest ACB news headline?

The most recent ACB headline (Jul 15, 2026) is "ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the ACB news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What ACB news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual ACB options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.